A Detroit Medical Center hospital has begun treating patients with the first gene therapy for beta-thalassemia, a rare blood ...

Prime Minister’s Youth Programme Chairman Rana Mashhood Ahmed Khan said on Monday that a vigorous awareness campaign was ...

Children’s Hospital of Michigan has announced a breakthrough in gene therapy for beta thalassemia, offering a potential cure ...

Children ages 12 and older with sickle cell are now eligible for a newly FDA-approved treatment through the MACC Fund Center ...

Conditions such as alpha thalassemia major, where the fetus cannot produce adequate red blood cells ... The condition can ...

Patients in Indore are now receiving advanced medical facilities, with the state's first government Super Speciality Hospital introducing haploidentical stem cell transplant (commonly known as haplo ...

Every five minutes, an individual in India is diagnosed with blood cancer or a related disorder. With only 0.09% of the ...

The MACC Fund Center for Cancer and Blood Disorders at Children’s Wisconsin is now offering a new gene therapy to children ...

For those with beta-0 thalassemia, their condition is usually more severe, while beta+ thalassemia tends to be milder. Treatment and Care The main goal of treatment is to reduce painful episodes and ...

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

CRISPR Therapeutics' first therapy is called Casgevy. It treats sickle cell disease (SCD) and beta thalassemia, both rare inherited illnesses that affect the function of a person's red blood cells. It ...